Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
L-DOS47
Also known as: formerly DOS47
print preview
bookmark
share with colleague
General Information
Company
Helix BioPharma Corp.
Description
Plant-derived urease combined with a highly specialized antibody agent to identify lung adenocarcinoma cells
Molecular Target
Not available
Mechanism of Action
Antibody
Latest Stage of Development
Phase I/II
Indication
Non-small cell lung cancer (NSCLC)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy